Composite Government Tracker Insider Trading Hedge Funds Red Flags Financials

Financials

BIIB

BIOGEN INC. · Biological Products, (No Diagnostic Substances)

Financials Score

★★★★★

Metrics Available10 / 10

You vs. Peer Average

Gross Margin

BIIB

117.7%

Peers

65.8%

Operating Margin

BIIB

28.7%

Peers

23.2%

Net Margin

BIIB

13.1%

Peers

18.9%

Revenue Growth (YoY)

BIIB

2.2%

Peers

2.4%

Earnings Growth (YoY)

BIIB

-20.8%

Peers

40.2%

Return on Equity

BIIB

7.1%

Peers

2.3%

Return on Assets

BIIB

4.4%

Peers

2.8%

Debt / Equity

BIIB

0.34x

Peers

0.68x

Current Ratio

BIIB

2.68x

Peers

3.69x

FCF Margin

BIIB

20.7%

Peers

24.1%